Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
AstraZeneca
Seagen Inc.
Mayo Clinic
Mayo Clinic
Kivu Bioscience Inc.
MediLink Therapeutics (Suzhou) Co., Ltd.
Neonc Technologies, Inc.
ViroMissile, Inc.
Bristol-Myers Squibb
Sichuan Enray Pharmaceutical Sciences Company
AstraZeneca
Tizona Therapeutics, Inc
Eli Lilly and Company
University of Colorado, Denver
MacroGenics
Karolinska University Hospital
SystImmune Inc.
Daiichi Sankyo
Eli Lilly and Company
Adela, Inc
Orano Med LLC
Radiopharm Theranostics, Ltd
Eli Lilly and Company
Medical College of Wisconsin
Innate Pharma
Mayo Clinic
Tanabe Pharma America, Inc.
Radiopharm Theranostics, Ltd
DualityBio Inc.
University of Pittsburgh
Massive Bio, Inc.
Rondo Therapeutics
University of Arizona
Chongqing Precision Biotech Co., Ltd
LigaChem Biosciences, Inc.
Washington University School of Medicine
Institut Claudius Regaud
Travera Inc
Nurix Therapeutics, Inc.
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
The Netherlands Cancer Institute
Yuhan Corporation
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
Anhui Provincial Hospital
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
HC Biopharma Inc.